查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378822

2023-2028 年按类型、应用（心室内不同步、心室间不同步、房室不同步）、最终用户和地区分類的心臟再同步治疗市场报告

Cardiac Resynchronization Therapy Market Report by Type, Application (Intraventricular Dyssynchrony, Interventricular Dyssynchrony, Atrioventricular Dyssynchrony), End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球心臟再同步治疗（CRT）市场规模达到54亿美元。展望未来， IMARC Group预计到2028年市场规模将达到77亿美元，2022-2028年复合年增长率（CAGR）为6.1%。心臟衰竭盛行率的上升、政府和监管支持的增加、有利的报销政策以及新兴经济体医疗基础设施的扩张是推动市场的一些主要因素。

心臟再同步治疗（CRT）是一种先进的医疗程序，用于治疗某些患者的心臟衰竭症状。这种治疗涉及使用一种透过手术植入胸部的专用设备，称为 CRT 设备，类似于起搏器。该装置的工作原理是向心室传输电脉衝，从而协调它们的收缩。这种同步可以提高心臟的效率，减轻经常伴随心臟衰竭的疲劳和呼吸急促等症状。对于患有中度至重度心臟衰竭且心臟内电紊乱证据的个体，通常会考虑 CRT 并结合最佳的药物治疗。 CRT的实施标誌着一种有针对性的心臟衰竭管理方法，旨在提高患者的生活品质和整体功能能力。

医疗保健基础设施的快速发展，特别是在新兴经济体，在扩大 CRT 设备的覆盖范围方面发挥着至关重要的作用，这将刺激预测期内的市场成长。随着各国投资现代化医疗设施、培训医疗保健专业人员和加强医疗保健系统，获得 CRT 等专业治疗的机会变得越来越普遍。再加上医疗旅游业的兴起，患者在以具有竞争力的成本提供先进医疗技术的国家寻求治疗，正在推动市场成长。此外，不断增加的公私伙伴关係正在促进政府和私人实体之间的合作，以资助和促进 CRT。透过教育活动和专业研讨会提高患者意识也促进了 CRT 的理解和接受，加快了产品的采用率。此外，製造商之间在产品开发、行销和分销方面的策略合作正在支持市场成长。除此之外，提供具有成本效益的 CRT 解决方案的本地製造商的出现正在促进竞争并使治疗更容易获得，从而推动心臟再同步治疗市场的成长。

心臟再同步治疗 (CRT) 市场趋势/驱动因素：

心臟衰竭盛行率增加

全球心臟衰竭发生率的上升是推动心臟再同步治疗（CRT）市场成长的关键因素。随着心臟衰竭变得越来越普遍，特别是在人口老化以及肥胖和糖尿病发病率增加的地区，对 CRT 等有效治疗方法的需求正在增加。 CRT 能够改善特定心臟衰竭患者的症状和整体生活品质，这凸显了其重要性。各种公共卫生措施也强调心臟衰竭的早期发现和治疗，进一步推动了对 CRT 的需求。这种慢性疾病的日益普及需要不断改进治疗解决方案，使 CRT 成为当代心臟衰竭管理策略不可或缺的一部分。

科技的快速进步

CRT 领域的技术创新和进步为全球市场的成长做出了重大贡献。主要参与者加大研发 (R&D) 力度，不断改进 CRT 设备，提升其功效、安全性和病患相容性。多点起搏和自适应演算法等创新正在实现更个人化和高效的治疗，满足心臟衰竭患者的多样化需求。先进技术的整合也有助于与其他医疗系统和患者监测工具的无缝协调。技术的不断发展将 CRT 的益处扩展到更广泛的患者群体，同时确保该疗法始终处于心臟衰竭治疗的前沿。

有利的政府和监管支持

政府和监管支援在塑造 CRT 市场方面发挥着至关重要的作用。透过提供明确的监管途径，政府正在促进新的和改进的 CRT 设备更快地获得批准。许多国家也投资于研究计划，并与产业参与者合作，以促进该领域的创新。此外，政府支持的卫生计划和政策的重点是减轻心臟衰竭的负担，因此支持 CRT 等治疗方法。监管机构与加强心臟衰竭护理目标的这种一致表明了一种坚定的方法，这有助于促进成长、标准化实践和确保 CRT 在各个医疗保健系统中的可及性。

心臟再同步治疗 (CRT) 产业细分：

IMARC Group提供了全球心臟再同步治疗 (CRT) 市场报告各细分市场的主要趋势分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据类型、应用程式和最终用户对市场进行了分类。

按类型划分：

CRT-去颤器

CRT心律调节器

CRT-除颤器代表最受欢迎的类型

该报告根据类型提供了详细的市场细分和分析。这包括 CRT 除颤器和 CRT 起搏器。根据该报告，CRT-除颤器占据了最大的细分市场。

CRT 去颤器 (CRT-D) 提供治疗心臟衰竭患者的双重功能。与标准 CRT 设备不同，CRT-D 结合了心臟再同步功能和去颤功能。这种整合方法使设备能够同步心室，提高其效率，并检测和纠正危及生命的心律不整。当检测到心律不整时，CRT-D 会向心臟发出电击，从而起到保护作用，为心臟骤停高风险患者提供额外的保护。 CRT-D 的包罗万象的性质扩展了其适用性，为治疗心臟衰竭的慢性症状和急性、严重心律不整提供了全面的解决方案。此外，设备小型化、电池寿命和可编程性的改进也促进了其普及。将功能整合到一台设备中，提供多方面的护理，使 CRT-D 成为首选，从而推动了该细分市场的成长。

按应用划分：

心室内不同步

室间 (VV) 不同步

房室 (AV) 不同步

心室内不同步主导市场

该报告根据应用程式提供了详细的市场细分和分析。这包括心室内不同步、室间 (VV) 不同步和房室 (AV) 不同步。根据该报告，心室内不同步是最大的部分。

心室内不同步是指心室收缩不协调，导致泵血效率低下和心臟衰竭症状恶化。这种特殊形式的不同步已在大量心臟衰竭患者中被发现，使其成为 CRT 的主要目标。 CRT 在治疗心室内不同步方面的应用已被广泛认可，可显着改善症状和整体心臟功能。透过 CRT 精确定位和纠正这种不同步，使心臟能够更有效地泵血，从而提高患者的生活品质并降低住院率。研究和临床试验进一步支持了 CRT 在此应用中的有效性，巩固了其作为标准治疗的地位。心臟衰竭患者普遍存在心室内不同步现象，而 CRT 在解决这种情况方面已被证明是成功的，这些都推动了该细分市场的成长。

按最终用户划分：

医院

心臟中心

门诊手术中心

其他的

医院占最大市场份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、心臟中心、门诊手术中心等。报告显示，医院占据了最大的市场。

医院通常是诊断和治疗心臟衰竭的主要场所，包括 CRT 设备的植入和管理。 CRT 的复杂性需要专门的设备、熟练的医疗保健专业人员以及协调的术后护理，而医院通常有能力提供这些资源。此外，较大的医院通常设有专门的心臟科室，配备经过 CRT 专门培训的专家，从而实现从初步咨询到术后监测的全面患者护理。许多医院也参与研究并与设备製造商合作，进一步与 CRT 的进步保持一致。对综合护理途径的重视，再加上医院环境内多学科团队的支持，确保患者获得无缝的体验。这种资源、专业知识和以患者为中心的护理的结合正在支持医院部门的成长。

按地区划分：

北美洲

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美在市场上表现出明显的主导地位

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

北美占据了最大的市场份额，因为该地区拥有先进的医疗基础设施、对医疗创新的重视以及强有力的监管支持，为 CRT 的采用和发展创造了有利的环境。北美也拥有大量领先的医疗研究机构和设备製造商，推动了CRT技术的持续创新。此外，医疗保健专业人员和一般大众对心臟衰竭及其治疗方案的认识程度较高，也有助于 CRT 的接受度不断提高。此外，导致心臟衰竭的生活方式相关疾病的盛行率相对较高，形成了庞大的患者基础。优惠的报销政策和保险范围进一步方便了患者接受 CRT 治疗。这些因素，加上对以患者为中心的护理的日益关注，使北美成为心臟再同步治疗 (CRT) 最大的区域市场。

竞争格局：

由于主要参与者积极参与研发 (R&D)，努力创新和增强 CRT 技术，市场正在稳步成长。他们与医疗保健机构合作，专注于创建提高效率、患者相容性以及与其他医疗保健系统整合的设备。扩展到新兴市场以及与当地经销商建立策略联盟也是其成长策略的一部分。透过收购和合作，这些产业领导者正在巩固自己的影响力、分享专业知识并促进技术进步。投资临床试验来验证新应用，并持续与监管机构合作以确保合规性，确保符合全球医疗保健需求。我们也预期市场将出现新进业者、产品组合整合以及策略合作的增加，以推动 CRT 领域内的良性竞争。

市场研究报告对全球心臟再同步治疗（CRT）市场的竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

雅培实验室

百多力股份公司

波士顿科学公司

利瓦诺瓦公司

麦迪科公司

美敦力公司

梅里特医疗系统公司

微创医疗科技有限公司

最近的发展：

2023 年 7 月，Biotronik SE & Co. KG 宣布美国食品药物管理局 (FDA) 批准其下一代 Amvia Edge 起搏器和心臟再同步治疗 (CRT) 设备产品组合。

雅培实验室 (Abbott Laboratories) 在心臟再同步治疗 (CRT) 领域取得了最新进展，发布了其植入式起搏器和除颤器的更新版本，展示了其不断改善患者护理的承诺。

本报告回答的关键问题：

  • 迄今为止，全球心臟再同步治疗（CRT）市场表现如何，未来几年将如何表现？
  • 全球心臟再同步治疗 (CRT) 市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球心臟再同步治疗 (CRT) 市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的心臟再同步治疗 (CRT) 市场？
  • 依类型划分市场是怎么样的？
  • 心臟再同步治疗 (CRT) 市场中哪种类型最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 心臟再同步治疗 (CRT) 市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 心臟再同步治疗 (CRT) 市场中哪个是最具吸引力的最终用户？
  • 全球心臟再同步治疗（CRT）市场的竞争结构如何？
  • 全球心臟再同步治疗 (CRT) 市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球心臟再同步治疗（CRT）市场表现如何，未来几年将如何表现？
  • 全球心臟再同步治疗 (CRT) 市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球心臟再同步治疗 (CRT) 市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的心臟再同步治疗 (CRT) 市场？
  • 依类型划分市场是怎么样的？
  • 心臟再同步治疗 (CRT) 市场中哪种类型最具吸引力？
  • 基于应用程式的市场区隔是什么？
  • 心臟再同步治疗 (CRT) 市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 心臟再同步治疗 (CRT) 市场中哪个是最具吸引力的最终用户？
  • 全球心臟再同步治疗（CRT）市场的竞争结构如何？
  • 全球心臟再同步治疗 (CRT) 市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心臟再同步治疗 (CRT) 市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按类型分類的市场细分

  • CRT-去颤器
    • 市场走向
    • 市场预测
  • CRT心律调节器
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 心室内不同步
    • 市场走向
    • 市场预测
  • 室间 (VV) 不同步
    • 市场走向
    • 市场预测
  • 房室 (AV) 不同步
    • 市场走向
    • 市场预测

第 8 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 心臟中心
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • LivaNova Plc
    • Medico SpA
    • Medtronic Plc
    • Merit Medical Systems Inc.
    • MicroPort Scientific Corporation
Product Code: SR112023A2787

Abstract

The global cardiac resynchronization therapy (CRT) market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2022-2028. The rising prevalence of heart failure, increase in government and regulatory support, favorable reimbursement policies, and expansion of healthcare infrastructure in emerging economies are some of the major factors propelling the market.

Cardiac resynchronization therapy (CRT) is an advanced medical procedure used to treat heart failure symptoms in certain patients. This treatment involves the use of a specialized device that is surgically implanted in the chest, known as a CRT device, which is akin to a pacemaker. The device functions by transmitting electrical impulses to the chambers of the heart, thereby coordinating their contractions. This synchronization can enhance the heart's efficiency, alleviating symptoms such as fatigue and shortness of breath that often accompany heart failure. CRT is typically considered for individuals with moderate to severe heart failure who display evidence of electrical disarray within the heart, in conjunction with optimal medical therapy. The implementation of CRT signifies a targeted approach to heart failure management, aimed at improving the quality of life and overall functional capacity of patients.

Rapid healthcare infrastructure development, particularly in emerging economies, is playing a vital role in expanding the reach of CRT devices, which will stimulate market growth during the forecast period. As nations invest in modernizing medical facilities, training healthcare professionals, and strengthening healthcare systems, access to specialized treatments like CRT is becoming more widespread. This, coupled with a rise in medical tourism, where patients seek treatment in countries offering advanced healthcare technologies at competitive costs, is fueling the market growth. Furthermore, the increasing public-private partnerships are fostering collaborations between governments and private entities to finance and promote CRT. Enhanced patient awareness through educational campaigns and professional workshops is also facilitating the understanding and acceptance of CRT, accelerating the product adoption rate. In addition, strategic collaborations between manufacturers for product development, marketing, and distribution are supporting market growth. Besides this, the emergence of local manufacturers offering cost-effective CRT solutions is fostering competition and making therapy more accessible, thus propelling the growth of the cardiac resynchronization therapy market.

Cardiac Resynchronization Therapy (CRT) Market Trends/Drivers:

Increase in Prevalence of Heart Failure

The rising incidence of heart failure globally is a key factor driving the growth of the cardiac resynchronization therapy (CRT) market. As heart failure becomes more prevalent, particularly in aging populations and areas with increased rates of obesity and diabetes, the demand for effective treatments like CRT is escalating. The ability of CRT to improve symptoms and overall quality of life in selected patients with heart failure underscores its importance. Various public health initiatives are also emphasizing early detection and treatment of heart failure, further propelling the need for CRT. The growing prevalence of this chronic condition necessitates continuous advancement in therapeutic solutions, making CRT an integral part of contemporary heart failure management strategies.

Rapid Technological Advancements

Technological innovation and advancements in the field of CRT are contributing significantly to the growth of the global market. Increased research and development (R&D) efforts by key players are continuously refining CRT devices, enhancing their efficacy, safety, and patient compatibility. Innovations like multi-point pacing and adaptive algorithms are enabling more personalized and efficient therapies, catering to the diverse needs of heart failure patients. The integration of sophisticated technologies also facilitates seamless coordination with other medical systems and patient monitoring tools. This constant evolution in technology is extending the benefits of CRT to a wider patient demographic while ensuring that the therapy remains at the forefront of heart failure treatment.

Favorable Government and Regulatory Support

Government and regulatory support play a crucial role in shaping the CRT market. By providing clear regulatory pathways, governments are facilitating faster approvals of new and improved CRT devices. Many countries are also investing in research initiatives and collaborating with industry players to foster innovation in the field. Moreover, government-backed health programs and policies are focusing on reducing the burden of heart failure and are thus endorsing treatments like CRT. This alignment of regulatory bodies with the objective of enhancing heart failure care demonstrates a committed approach, which is instrumental in fostering growth, standardizing practices, and ensuring the accessibility of CRT across various healthcare systems.

Cardiac Resynchronization Therapy (CRT) Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global cardiac resynchronization therapy (CRT) market report, along with forecasts at the global, regional, and country levels for 2023-2028. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

CRT-Defibrillator

CRT-Pacemaker

CRT-Defibrillator represents the most popular type

The report has provided a detailed breakup and analysis of the market based on the type. This includes CRT-Defibrillator and CRT-Pacemaker. According to the report, CRT-Defibrillator represented the largest segment.

The CRT-Defibrillator (CRT-D) offers dual functionality in treating heart failure patients. Unlike standard CRT devices, CRT-D combines the features of cardiac resynchronization with defibrillation capabilities. This integrated approach enables the device to synchronize the heart's chambers, improving its efficiency, as well as to detect and correct life-threatening arrhythmias. By delivering a shock to the heart when it detects irregular rhythms, the CRT-D acts as a safeguard, adding an extra layer of protection for patients at high risk of sudden cardiac arrest. The all-encompassing nature of CRT-D extends its applicability, offering a comprehensive solution for managing both the chronic symptoms of heart failure and acute, critical arrhythmias. Additionally, improvements in device miniaturization, battery life, and programmability have contributed to its popularity. This consolidation of functions into one device, providing multifaceted care, has made CRT-D a preferred option, thus fueling the segment growth.

Breakup by Application:

Intraventricular Dyssynchrony

Interventricular (V-V) Dyssynchrony

Atrioventricular (A-V) Dyssynchrony

Intraventricular Dyssynchrony dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes intraventricular dyssynchrony interventricular (V-V) dyssynchrony, and atrioventricular (A-V) dyssynchrony. According to the report, intraventricular dyssynchrony represented the largest segment.

Intraventricular dyssynchrony refers to the uncoordinated contraction of the heart's ventricles, leading to inefficient pumping and worsening heart failure symptoms. This specific form of dyssynchrony has been identified in a significant number of heart failure patients, making it a primary target for CRT. The use of CRT in managing intraventricular dyssynchrony is well-established, offering marked improvements in both symptoms and overall cardiac function. The precise targeting and correction of this dyssynchrony through CRT enables the heart to pump more efficiently, enhancing the patient's quality of life and reducing hospitalization rates. Research studies and clinical trials have further supported the effectiveness of CRT in this application, solidifying its position as a standard treatment. The pervasive presence of intraventricular dyssynchrony among heart failure patients and the proven success of CRT in addressing this condition are fueling the segment growth.

Breakup by End User:

Hospitals

Cardiac Centers

Ambulatory Surgery Centers

Others

Hospitals hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, cardiac centers, ambulatory surgery centers, and others. According to the report, hospitals accounted for the largest market share.

Hospitals are often the primary setting for the diagnosis and treatment of heart failure, including the implantation and management of CRT devices. The complexity of CRT requires specialized equipment, skilled healthcare professionals, and coordinated post-procedure care, resources that hospitals are typically well-equipped to provide. Additionally, larger hospitals often have dedicated cardiac units with experts trained specifically in CRT, enabling comprehensive patient care from initial consultation through post-surgical monitoring. Many hospitals also engage in research and collaborate with device manufacturers, further aligning themselves with the advancements in CRT. The emphasis on integrated care pathways, coupled with the support of multi-disciplinary teams within the hospital setting, ensures that patients receive a seamless experience. This combination of resources, expertise, and patient-centric care is supporting the growth of the hospital segment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region boasts a sophisticated healthcare infrastructure, emphasis on medical innovation, and robust regulatory support that have fostered a favorable environment for the adoption and advancement of CRT. North America is also home to a significant number of leading medical research institutions and device manufacturers, promoting continuous innovation in CRT technology. In addition, high awareness levels among healthcare professionals and the general population about heart failure and its treatment options contribute to the growing acceptance of CRT. Moreover, the prevalence of lifestyle-related diseases leading to heart failure is relatively high in this region, creating a substantial patient base. Favorable reimbursement policies and insurance coverage further ease the accessibility of CRT for patients. These factors, along with the increasing focus on patient-centered care, position North America as the largest regional market for cardiac resynchronization therapy (CRT).

Competitive Landscape:

The market is experiencing steady growth as key players are actively engaged in research and development (R&D), striving to innovate and enhance CRT technology. Collaborating with healthcare institutions, they are focused on creating devices with improved efficiency, patient compatibility, and integration with other healthcare systems. Expansion into emerging markets and strategic alliances with local distributors are also part of their growth strategies. Through acquisitions and partnerships, these industry leaders are consolidating their presence, sharing expertise, and fostering technological advancements. Investments in clinical trials to validate new applications and continued engagement with regulatory bodies for compliance ensure alignment with global healthcare needs. We also expect the market to witness new entrants, consolidation of portfolios, and a rise in strategic collaborations to drive healthy competition within the CRT domain.

The market research report has provided a comprehensive analysis of the competitive landscape in the global cardiac resynchronization therapy (CRT) market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Biotronik SE & Co. KG

Boston Scientific Corporation

LivaNova Plc

Medico S.p.A.

Medtronic Plc

Merit Medical Systems Inc.

MicroPort Scientific Corporation

Recent Developments:

In July 2023, Biotronik SE & Co. KG announced the approval of its next-generation portfolio of Amvia Edge pacemakers and cardiac resynchronization therapy (CRT) devices by the U.S. Food and Drug Administration (FDA).

Abbott Laboratories has made recent developments in cardiac resynchronization therapy (CRT) by releasing updates to its implantable pacemakers and defibrillators, showcasing its commitment to continuously improve patient care.

Key Questions Answered in This Report:

  • How has the global cardiac resynchronization therapy (CRT) market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global cardiac resynchronization therapy (CRT) market?
  • What is the impact of each driver, restraint, and opportunity on the global cardiac resynchronization therapy (CRT) market?
  • What are the key regional markets?
  • Which countries represent the most attractive cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the cardiac resynchronization therapy (CRT) market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the cardiac resynchronization therapy (CRT) market?
  • What is the competitive structure of the global cardiac resynchronization therapy (CRT) market?
  • Who are the key players/companies in the global cardiac resynchronization therapy (CRT) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Resynchronization Therapy (CRT) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 CRT-Defibrillator
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CRT-Pacemaker
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Intraventricular Dyssynchrony
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Interventricular (V-V) Dyssynchrony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Atrioventricular (A-V) Dyssynchrony
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgery Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biotronik SE & Co. KG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boston Scientific Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 LivaNova Plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Medico S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Merit Medical Systems Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 MicroPort Scientific Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio

List of Figures

  • Figure 1: Global: Cardiac Resynchronization Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2022
  • Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2022
  • Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2022
  • Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
  • Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
  • Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cardiac Resynchronization Therapy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Cardiac Resynchronization Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Cardiac Resynchronization Therapy Market Structure
  • Table 7: Global: Cardiac Resynchronization Therapy Market: Key Players